KNSA vs W · P/E 53, rev $677.6M vs rev $6.45B
Kiniksa Pharmaceuticals Ltd (KNSA) versus Wayfair Inc (W) — a side-by-side from cached financials, not a winner call.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Wayfair Inc (W) is a internet retail company listed on NYSE.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Latest reported W revenue for 2026-06-30 was $6.45B. Net income was -$106.0M. W currently screens at market cap $10.77B.
KNSA currently screens at market cap $3.73B and trailing P/E 53.2. W currently screens at market cap $10.77B.
Not investment advice. Open the KNSA and W stock pages for the full models.
Not investment advice.